TD Asset Management Inc Sells 627,396 Shares of Colgate-Palmolive Company $CL

TD Asset Management Inc lowered its holdings in Colgate-Palmolive Company (NYSE:CL) by 17.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,911,008 shares of the company’s stock after selling 627,396 shares during the quarter. TD Asset Management Inc owned 0.36% of Colgate-Palmolive worth $232,706,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Brighton Jones LLC boosted its stake in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after acquiring an additional 450 shares during the last quarter. Woodline Partners LP increased its position in Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after buying an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. raised its stake in shares of Colgate-Palmolive by 2.0% in the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock worth $1,136,000 after buying an additional 245 shares during the period. Resonant Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 2nd quarter valued at about $233,000. Finally, Envestnet Asset Management Inc. grew its stake in shares of Colgate-Palmolive by 0.4% during the 2nd quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock valued at $61,662,000 after acquiring an additional 2,768 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 1.0%

Shares of Colgate-Palmolive stock opened at $98.08 on Wednesday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The firm’s 50 day moving average price is $86.35 and its 200-day moving average price is $82.43. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. The company has a market cap of $79.06 billion, a P/E ratio of 37.43, a PEG ratio of 4.38 and a beta of 0.29.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a yield of 2.1%. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Insiders Place Their Bets

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the transaction, the chief operating officer directly owned 10,415 shares in the company, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider John Hazlin sold 20,989 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the sale, the insider owned 17,645 shares in the company, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 184,683 shares of company stock valued at $17,486,693 in the last three months. 0.41% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Citigroup increased their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Bank of America boosted their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. UBS Group increased their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Key Headlines Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Market/momentum upgrade: CL has been upgraded on relative strength metrics and is noted as up ~23% YTD, which has sparked momentum buying and technical interest. This upgrade supports further inflows from momentum-focused funds and retail investors. Colgate-Palmolive Stock Up 23% So Far This Year, Shines Brightly. Gets Rating Upgrade.
• Positive Sentiment: Analyst/portfolio spotlight: Zacks and other outlets are highlighting CL in model portfolios and focus lists after recent strength—this can attract coverage-driven buying and validate recent upgrades. Take the Zacks Approach to Beat the Markets
• Positive Sentiment: Emerging-market sales/brand initiative: Colgate-Palmolive (India) announced a Haryana government tie-up to deliver oral-health education to millions of students—strengthening local brand presence and long-term category penetration. Colgate-Palmolive, Haryana Government Tie Up
• Positive Sentiment: Industry tailwinds: A broad cosmetics/personal-care market report lists Colgate among major players and forecasts sector growth—supportive for medium-term revenue/innovation upside. Global Cosmetics Market Competitive Landscape Report 2025
• Neutral Sentiment: Analyst commentary and peer comparisons: Multiple pieces compare CL with peers (e.g., P&G) across margins, pricing power and valuation—useful context but not a direct catalyst. Procter & Gamble vs Colgate
• Neutral Sentiment: Technical watch: Coverage notes rising relative strength but CL remains shy of key thresholds—momentum may continue but technical resistance could slow gains. Colgate-Palmolive shows rising relative strength; still shy of key threshold
• Negative Sentiment: Execution risk disclosure: Analysts flagged execution risks tied to Colgate’s new three‑year strategic growth and productivity program—if execution slips, margins and guidance could be at risk. Execution Risks Loom Over Colgate-Palmolive’s 3-Year Program
• Negative Sentiment: Governance/proxy friction: Colgate plans to oppose a shareholder proposal to remove DEI-related board selection criteria—this governance fight could create investor uncertainty and negative headlines. Colgate-Palmolive plans to defend DEI criteria for board selection
• Negative Sentiment: Options/short-term hedging: Unusual options flow shows a big jump in put buying (18,150 puts), indicating some investors are hedging or betting on near-term weakness—could amplify volatility.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.